Borgeson Blake Insider Trading Activity
Borgeson Blake has been net-selling over the last 12 months with 0 purchases and 8 sales across 1 company.
RXRX is the most-traded position with 8 trades. The largest single transaction was a sale of RXRX for $961K on Dec 2, 2025.
Performance Scorecard
Forward stock performance after each transaction by Borgeson Blake. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +4.5% | 57% | 7 |
| 90 days | — | +6.6% | 60% | 5 |
| 120 days | — | +15.7% | 75% | 4 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersRXRX · RECURSION PHARMACEUTICALS, INC.
🔒 Subscribe to see trade entries
Pro members see exactly when Borgeson Blake bought and sold RXRX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jul 7, 2026 | RXRX | Sell | 40,000 | $3.96 | $159K | −0.6% | Director | |
Jun 2, 2026 | RXRX | Sell | 30,000 | $3.68 | $110K | −0.5% | Director | |
May 5, 2026 | RXRX | Sell | 30,000 | $3.52 | $106K | −0.5% | Director | |
Apr 7, 2026 | RXRX | Sell | 30,000 | $3.10 | $93K | −0.5% | Director | |
Mar 3, 2026 | RXRX | Sell | 170,000 | $3.46 | $588K | −2.6% | Director | |
Feb 3, 2026 Filed 3d late | RXRX | Sell | 220,000 | $4.20 | $924K | −3.3% | Director | |
Jan 6, 2026 | RXRX | Sell | 220,000 | $4.36 | $959K | −3.2% | Director | |
Dec 2, 2025 | RXRX | Sell | 220,000 | $4.37 | $961K | −3.1% | Director |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | 8 | $3.9M |
Other insiders at RECURSION PHARMACEUTICALS, INC.
3 other tracked filers at RXRX.